Beth A. Burnside
39Patents
20h-index
31Co-inventors
85Inventor score
Filing activity: May 22, 1995 → Jun 29, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6322819A | Oral pulsed dose drug delivery system | Human Necessities | 243 | Expired |
| US6913768B2 | Sustained release delivery of amphetamine salts | Human Necessities | 179 | Expired |
| US6287599A | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles | Human Necessities | 145 | Expired |
| US6605300B1 | Oral pulsed dose drug delivery system | Human Necessities | 97 | Expired |
| US5824638A | Oral insulin delivery | Human Necessities | 95 | Expired |
| US6811794B2 | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles | Human Necessities | 74 | Expired |
| US7011846B2 | Oral capsule formulation with increased physical stability | Human Necessities | 71 | Expired |
| US6284276A | Soluble form osmotic dose delivery system | Human Necessities | 69 | Expired |
| US6110498A | Osmotic drug delivery system | Human Necessities | 60 | Expired |
| US6361796B1 | Soluble form osmotic dose delivery system | Human Necessities | 54 | Expired |
| US6692767B2 | Solid solution beadlet | Human Necessities | 51 | Expired |
| US5952004A | Emulsified drug delivery systems | Human Necessities | 43 | Expired |
| US6814979B2 | Osmotic drug delivery system | Human Necessities | 42 | Expired |
| USRE41148E1 | Oral pulsed dose drug delivery system | General | 38 | Expired |
| US6838093B2 | System for osmotic delivery of pharmaceutically active agents | Human Necessities | 29 | Expired |
| USRE42096E1 | Oral pulsed dose drug delivery system | General | 28 | Expired |
| US5897876A | Emulsified drug delivery system | Human Necessities | 27 | Expired |
| US6514532B2 | Soluble form osmotic dose delivery system | Human Necessities | 21 | Expired |
| US8906413B2 | Drug formulations having reduced abuse potential | Human Necessities | 20 | Expired |
| US6890918B2 | Pharmaceutical compositions including ACE/NEP inhibitors and bioavailability enhancers | Human Necessities | 20 | Expired |
| US5948407A | Oral induction of tolerance to parenterally administered non-autologous polypeptides | Emerging Cross-Sectional Technologies | 11 | Expired |
| US5883103A | Oral acyclovir delivery | Human Necessities | 11 | Expired |
| US6793934B1 | Solid oral dosage form | Human Necessities | 11 | Expired |
| US7022337B2 | Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8062672B2 | Antibiotic product, use and formulation thereof | Human Necessities | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.